Alendronate
Active substance: alendronate
TABLET · ALENDRONATE SODIUM 35 mg/1
United StatesActive
Marketing holder: Marlex Pharmaceuticals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ALENDRONATE SODIUM · 35 mg/1
Registration
- Registration number
- 10135-718
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 10135-718 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10135-718 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10135-718 · Verified 2026-10-09 · open in source